By Benjamin Horney ( September 16, 2019, 4:16 PM EDT) -- Danish drugmaker Lundbeck on Monday agreed to buy Alder BioPharmaceuticals, which develops treatments for migraines and autoimmune and inflammatory diseases, for as much as $1.95 billion, in a deal driven by Baker McKenzie, Skadden and Cooley....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.